PUERPERAL INFECTIONS
TREATMENT WITH SALVARSAH MEDICAL RESEARCH COUNCIL’S REPORT. Press Association —By Telegraph—Copyright, LONDON, February 28. (Received February 29, at 12.55 p.m.) Following up Dr Colebrook’s and Captain S. R. Douglas’s war-time investigation into tho possibility of sa'«varsun and the new salvarsan being used in the treatment of septicaemia, Dr Colobrook has lately extended his investigations to puerperal infections. The Medical Research Council publishes his report, which takes into account tho possibility of a chemotherapeutic agent defeating its own ends by the concurrent poisoning of the body cells. Summing up, the report says that, although there is ground for believing that the administration of these larsenicals sometimes leads to destruction of streptococci and assists patients to recovery, this should not be expected in all cases. Therefore it is necessary that careful clinical tests be carried out to determine precisely how much can be achieved.—A. and N.Z. and ‘ Sim ’ Cable.
[Salvarsan is the German trade name for arsenobenzol or 606, so-called from its number in a series investigated. It was discovered synthetically by Ehrlicli and Hnta in 39(17. It is used mainly for the treatment of syphilis.]
Permanent link to this item
Hononga pūmau ki tēnei tūemi
https://paperspast.natlib.govt.nz/newspapers/ESD19280229.2.84
Bibliographic details
Ngā taipitopito pukapuka
Evening Star, Issue 19803, 29 February 1928, Page 6
Word count
Tapeke kupu
186PUERPERAL INFECTIONS Evening Star, Issue 19803, 29 February 1928, Page 6
Using this item
Te whakamahi i tēnei tūemi
Allied Press Ltd is the copyright owner for the Evening Star. You can reproduce in-copyright material from this newspaper for non-commercial use under a Creative Commons New Zealand BY-NC-SA licence. This newspaper is not available for commercial use without the consent of Allied Press Ltd. For advice on reproduction of out-of-copyright material from this newspaper, please refer to the Copyright guide.
Log in